Mounjaro is injected once weekly
Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F
GPR43 - A Prototypic Metabolite Sensor Linking Metabolic and Inflammatory Diseases
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
In this particular case, were providing additional access to beneficiaries who wouldnt otherwise be covered by Medicare for obesity indications, and so theres access to additional patients who could really benefit from these medications, and thats mutually beneficial for both the taxpayer, for those beneficiaries, as well as for the companies
And as their tissue levels of glutathione increased, the inflammation subsided